Please complete the CAPTCHA to continue
@regeneron.com
✓
2 phones found area 650
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Thinh Nguyen Duc, Ph.D. is listed as Senior Director of Business Development at Regeneron, based in New York, United States. AeroLeads shows a work email signal at regeneron.com, phone signal with area code 650, and a matched LinkedIn profile for Thinh Nguyen Duc, Ph.D..
Thinh Nguyen Duc, Ph.D. previously worked as Director of Business Development at Regeneron and Manger/Sr Manager/Associate Director/Director of Corporate Strategy at Regeneron. Thinh Nguyen Duc, Ph.D. holds B.S. In Biology (Honors); M.S. In Management Science. from Stanford University.
This section adds company-level context without repeating Thinh Nguyen Duc, Ph.D.'s masked contact details.
AeroLeads found 1 current-domain work email signal for Thinh Nguyen Duc, Ph.D.. Compare company email patterns before reaching out.
Announced transactions: - $100M research collaboration with Mammoth Biosciences (2024)- Global (LATAM, CEE, Australia/NZ) commercial distribution for Libtayo (anti-PD1) (undisclosed upfront, financials) (2023)- $1.1B Acquisition of global right to Libtayo (anti-PD1). $900M upfront, $200M in milestone payments (2022) - Investment (undisclosed financials) and development agreement with Ultima Genomics (2022)- $3B repurchase of Regeneron’s stock (2021)- $11.7B repurchase and secondary offering of 23M shares of Regeneron stock held by Sanofi (2020)- Inaugural $1B repurchase of Regeneron’s stock (2019)- $230M WW development and commercialization agreement to out-license two clinical-stage assets and two preclinical assets in oncology from Vertex to Merck KGaA (2017)
Listed skills include Molecular Biology, Commercialization, Data Analysis, Research, and 6 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Tarrytown, New York, Us
•Announced deals: - $100M research collaboration with Mammoth Biosciences.- $1.1B purchase of global right to Libtayo from SNY. - Distribution agreements (full agency) in LATAM, CEE, Australia, New Zealand, South Korea and Taiwan for Libtayo (undisclosed upfront and financials.) - Equity investment in Ultima Genomics (undisclosed financials.)
Tarrytown, New York, Us
•Corporate finance strategy:-Led EPS accretion, cash and debt impact analyses for an $11.7B secondary public offering/buyback of shares owned by Sanofi-Led valuation and analysis to support share buyback programs ($5B+)•New Product Planning:-Revenue and valuation analyses to inform (1) indication prioritization, (2) budget discussion with senior management, (3) go/no-go clinical and launch decisions •Research strategy:- Designed and implemented a framework to assess and prioritize research effort of the 1800+ person research organization-Work resulted in broad organizational changes to the research organization•Long range planning:-Co-led the LRP process: work closely with R&D, Commercial and Finance to develop a 5 year topline and expense outlook annually-Owned detailed 5 year corporate P&L and cash flow models
Boston, Ma, Us
•Life Sciences Practice. Worked with biotech and pharma clients on BD screens, commercial assessment and corporate valuation.
New York, Ny, Us
•Trained in peptide chemistry, organic synthesis, molecular and cell biology.Nguyen Duc, T., Huse, M., A generalization platform for the photo-activation of cell surface receptor. ACS CHEMICAL BIOLOGY. Aug, 2015 *Selected as cover article Paige, J., Nguyen Duc, T., et. al., Fluorescence imaging of intracellular metabolites with RNA. SCIENCE. March, 2012 *Faculty of 1000’s selection as exceptional research article.
Palo Alto, California, Us
•Synthesized and tested in animal models protease inhibitors and imaging reagents for the inhibition and detection of early tumor formation and metastasis. PI: Matthew Bogyo, Ph.DMorell, M., Nguyen Duc, T., et. al., Coupling Protein Engineering with Probe Design to Inhibit and Image Matrix Metalloproteinases with Controlled Specificity, JACS. May, 2013 *Highlighted by NATURE ChemBio.
Quick answers generated from the profile data available on this page.
Thinh Nguyen Duc, Ph.D. works for Regeneron.
Thinh Nguyen Duc, Ph.D. is listed as Senior Director of Business Development at Regeneron.
AeroLeads has found 1 work email signal at @regeneron.com for Thinh Nguyen Duc, Ph.D. at Regeneron.
AeroLeads has found 2 phone signal(s) with area code 650 for Thinh Nguyen Duc, Ph.D. at Regeneron.
Thinh Nguyen Duc, Ph.D. is based in New York, United States while working with Regeneron.
Thinh Nguyen Duc, Ph.D. has worked for Regeneron, L.E.K. Consulting, Memorial Sloan Kettering Cancer Center, and Stanford Health Care.
You can use AeroLeads to view verified contact signals for Thinh Nguyen Duc, Ph.D. at Regeneron, including work email, phone, and LinkedIn data when available.
Thinh Nguyen Duc, Ph.D. holds B.S. In Biology (Honors); M.S. In Management Science. from Stanford University.
Thinh Nguyen Duc, Ph.D. is listed with skills including Molecular Biology, Commercialization, Data Analysis, Research, Immunology, Life Sciences, Cell Culture, and Western Blotting.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts